Pages that link to "Q36110174"
Jump to navigation
Jump to search
The following pages link to Stimulants and the developing brain (Q36110174):
Displaying 50 items.
- The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder (Q22241830) (← links)
- Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants (Q22251215) (← links)
- Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats (Q23915181) (← links)
- Influence of methylphenidate on brain development--an update of recent animal experiments (Q24537917) (← links)
- Desperately driven and no brakes: developmental stress exposure and subsequent risk for substance abuse (Q24653305) (← links)
- Reducing substance use during adolescence: a translational framework for prevention (Q27023852) (← links)
- Sensitive periods of substance abuse: Early risk for the transition to dependence (Q28075281) (← links)
- Comparing Auditory Noise Treatment with Stimulant Medication on Cognitive Task Performance in Children with Attention Deficit Hyperactivity Disorder: Results from a Pilot Study. (Q30374187) (← links)
- Differences in Speech Recognition Between Children with Attention Deficits and Typically Developed Children Disappear When Exposed to 65 dB of Auditory Noise. (Q30391541) (← links)
- Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. (Q30395001) (← links)
- Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects (Q30419091) (← links)
- Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high‐dose methamphetamine administration (Q30443801) (← links)
- Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety (Q30450488) (← links)
- Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats (Q30547324) (← links)
- Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments (Q30581979) (← links)
- What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). (Q30596479) (← links)
- Perinatal caffeine, acting on maternal adenosine A(1) receptors, causes long-lasting behavioral changes in mouse offspring (Q30855196) (← links)
- Prenatal cocaine exposure alters alpha2 receptor expression in adolescent rats (Q33240171) (← links)
- An integrative approach to determine the best behavioral and biological markers of methylphenidate. (Q33283331) (← links)
- Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers? (Q33691271) (← links)
- Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients (Q33897101) (← links)
- Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes (Q33907518) (← links)
- Development of eye-movement control (Q34014247) (← links)
- Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum. (Q34065820) (← links)
- Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat. (Q34441382) (← links)
- The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals (Q34463526) (← links)
- Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study (Q34505716) (← links)
- Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models (Q34513218) (← links)
- Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. (Q34687232) (← links)
- Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates. (Q34707811) (← links)
- Early methylphenidate exposure enhances cocaine self-administration but not cocaine-induced conditioned place preference in young adult rats (Q34787716) (← links)
- Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats. (Q34869580) (← links)
- Annual Research Review: New frontiers in developmental neuropharmacology: can long‐term therapeutic effects of drugs be optimized through carefully timed early intervention? (Q35046638) (← links)
- Ontogeny and regulation of the serotonin transporter: providing insights into human disorders (Q35090255) (← links)
- Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior (Q35090725) (← links)
- Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a (Q35096339) (← links)
- Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder (Q35205459) (← links)
- One-trial behavioral sensitization in preweanling rats: differential effects of cocaine, methamphetamine, methylphenidate, and D-amphetamine (Q35243282) (← links)
- Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood (Q36372705) (← links)
- Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats. (Q36374387) (← links)
- Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations (Q36466075) (← links)
- Early ontogeny of D-amphetamine-induced one-trial behavioral sensitization (Q36675304) (← links)
- Effects of Stimulants and SSRIs on Brain Function in Children: Emerging Clues from fMRI Studies (Q36808192) (← links)
- Developmental disruption of gamma-aminobutyric acid function in the medial prefrontal cortex by noncontingent cocaine exposure during early adolescence (Q37042903) (← links)
- Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats. (Q37108103) (← links)
- Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization (Q37147049) (← links)
- Long-lasting dysregulation of gene expression in corticostriatal circuits after repeated cocaine treatment in adult rats: effects on zif 268 and homer 1a. (Q37186534) (← links)
- Ontogeny of methamphetamine-induced and cocaine-induced one-trial behavioral sensitization in preweanling and adolescent rats (Q37213068) (← links)
- Pleiotropic effects of neurotransmission during development: modulators of modularity (Q37224539) (← links)
- Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood (Q37497626) (← links)